Rodman & Renshaw Initiates Analyst Coverage on Quantum BioPharma with a BUY Rating and US$8 Price Target Sep 17, 2026 08:00AM
Rodman & Renshaw Starts (QNTM) at Buy Aug 31, 2026 07:03AM